What Is Clinical Trial Prescreening?

Prescreening vs. Clinical Screening

For a deeper comparison, see Prescreening vs. Screening: What’s the Difference?

Where Prescreening Sits in the Enrollment Pipeline

Prescreening sits between initial intake and formal site review. The workflow should keep responsibility clear without shifting clinical decisions away from the research site.

1. 01

   Inquiry enters the workflow

   A prospective participant expresses interest or is referred.

2. 02

   Information is organized

   Candidate-reported information is collected according to the permitted workflow.

3. 03

   Preliminary questions are addressed

   The candidate responds to site-approved preliminary questions.

4. 04

   Unresolved information is flagged

   Questions requiring clinical or protocol interpretation remain identified for authorized site review rather than being interpreted by Consent2Randomize.

5. 05

   Structured handoff reaches the site

   The research team receives organized information and retains all clinical decisions.

For more on how intake and prescreening connect, see how intake quality impacts prescreening performance. For the broader operating framework, see the enrollment operations overview.

The Six Core Functions of Clinical Trial Prescreening

Six core functions organize preliminary information and prepare the record for authorized site review.

• 01

  Site-approved preliminary question set

  A site-approved checklist defines the preliminary information to collect before formal review.

• 02

  Candidate-reported information documentation

  Candidate-reported responses are documented and organized so coordinators receive a structured summary rather than raw contact notes.

• 03

  Candidate engagement and preparation

  Prescreening conversations can provide site-approved study information, time commitments, and expectations before formal site review.

• 04

  Handoff readiness preparation

  Before handoff, the workflow can document information shared, scheduling availability where permitted, and record readiness for coordinator review.

• 05

  Prescreening outcome documentation

  Each interaction produces a structured record of information collected, missing or unresolved items, and the next step for authorized site review.

• 06

  Site handoff package preparation

  The handoff can include candidate-reported responses, answers to site-approved preliminary questions, contact and appointment status, unresolved or unclear information, and items requiring authorized site review.

How Prescreening Quality Relates to Screen Failure

When incomplete or unresolved information reaches the site, coordinators may need extra time before the appropriate next step is clear. Structured preliminary prescreening can identify gaps earlier and may help address some avoidable causes of screen failure, but it does not guarantee lower rates or replace site screening.

Permitted information may include age range, candidate-reported diagnosis or treatment history, candidate-reported medication information requested through the site-approved preliminary question set, and geographic or scheduling constraints. Clinical or protocol interpretation remains for authorized site review.

For a more detailed evidence-aware discussion, see reducing screen failures through better prescreening and prescreening metrics that research sites should track.

What Site-Approved Prescreening Looks Like

Site-approved prescreening begins with the site’s permitted preliminary question set. The site defines what may be requested, shared, documented, and escalated for review.

Trained staff can document responses, identify missing items, and preserve unresolved clinical or protocol questions. The record may include contact history, scheduling context where permitted, candidate-reported information, and items requiring authorized site review.

For prospective participants, a structured process may clarify what information is requested, what happens next, and which questions belong with the research site.

The result is a more organized starting point for the coordinator team without converting preliminary support into eligibility determination. For implementation detail, see prescreening workflows for research sites.

How Structured Prescreening Can Support Coordinator Capacity

Clinical research coordinators manage clinical, regulatory, participant-facing, and administrative responsibilities. Fragmented preliminary information adds time spent reconstructing history, clarifying missing details, or deciding which questions require site review.

Dedicated enrollment support can organize preliminary information before coordinator review. Clinical review remains essential, but it can begin from a clearer record with missing and unresolved items identified.

For a broader view, see coordinator capacity, how clinical trial prescreening supports enrollment operations, and the Screen Failure Reduction Playbook.